Diagnosed with Relapsing Multiple Sclerosis?
Consider joining the ENSURE clinical study


About the ENSURE Study
The ENSURE study is a clinical study of a potential new oral study drug for patients diagnosed with relapsing multiple sclerosis (RMS), a chronic disease affecting the brain and spinal cord. Patients with multiple sclerosis can experience a variety of symptoms, including problems with vision, bladder control, arm or leg movement, sensation or balance. Relapsing MS is characterized by attacks, also called relapses, meaning new or worsening of symptoms, lasting for at least 24 hours before full or partial recovery.
The purpose of the ENSURE study is to investigate how well the oral study drug works and how safe it is in patients with RMS. The study will be conducted at around 100 medical sites worldwide and 1050 patients are planned to take part in this clinical study.
Who Can Participate?
Short Study Summary
Medical Condition:
Study Duration:
Phase:
What are the Next Steps if I am Interested to Participate in the ENSURE Study?
There are other criteria that need to be fulfilled to be able to take part in the ENSURE study.
If you decide you want to join the ENSURE study and if your study doctor confirms that you could be a good match, you will be asked to visit the study clinic for a screening visit. During this visit, you will be asked to read the study information and sign an informed consent form before any procedures are performed.
Additional tests will be performed to determine if your qualify to participate in the study.
To find out if the study may be suitable for you, please click the button:
STEP 1
Answer some questions about your RMS to ensure that this study is right for you.
STEP 2
A nurse will get in touch with you on the phone to ask some additional questions about your RMS.
STEP 3
You will be contacted by the study clinic to schedule a screening visit.
What Does It Mean to Participate in the ENSURE Study?
about
1.5 years
Main treatment period
up to
8 years
Extended treatment period
You will need to return to the study site after 4 weeks, and then every 24 weeks for up to 8 years to be evaluated. Your participation is completely voluntary. You can choose to leave at any time without any further explanation and without any impact on your future care.

For additional information about clinical studies in general please see the FAQ-section
Frequently Asked Questions
What is a clinical study?
Clinical studies are scientific studies in which new medicines and treatments are tested to make sure they are safe and effective for people to take and use. They are one of the most important steps in bringing new treatments to patients.
Why is clinical research important?
Clinical trials rely on the participation of volunteers in order to succeed. On average, it can take up to 8 years for a new treatment to reach the public, the major hold-up being how long it takes to complete the clinical trials (often due to shortage of participants).
All new medical treatments and drugs have gone through clinical trials to make sure that they are safe and effective.
Who runs clinical studies?
Every clinical study is led by a principal investigator, who is often a medical doctor. Clinical studies also have a research team that may include doctors, nurses, social workers, and other health care professionals.
What are the phases of clinical research studies?
Clinical studies are conducted in different phases:
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the effect in various populations and any side effects associated with long-term use.
What does it mean to participate?
Before taking part in a trial, you are informed about what it means to participate in the study, including how the study is conducted, how you are protected during the study and the risks and benefits of participating. You may choose to end your participation in the study at any time.
You should learn about the risks and benefits of any clinical trial before you agree to take part in a trial. Talk to your doctor about specific trials you’re interested in.